C urrent strategies to minimize ischemic insults after traumatic brain injury (TBI) rely on preventing intracranial hypertension and maintaining an appropriate cerebral perfusion pressure (CPP). However, ischemic insults can occur in the setting of normal intracranial pressure (ICP) and adequate CPP. Recent studies demonstrate consistent relationships between BTpO 2 and conventional measures such as ICP, mean arterial pressure (MAP), CPP, and fraction of inspired oxygen (FIO 2 ) (1-3). The true significance of this developing parameter should best be evaluated by its relationship to functional outcome after hospitalization for TBI patients.
Initial animal studies as early as 1968 have established the precision of continuous sampling of the partial pressure of brain tissue oxygen (BTpO 2 ) with a polarographic Clark-type microelectrode (Licox, Integra Neurosciences, Plainsboro, NJ) (4, 5) . Since its introduction to clinical management of TBI patients, tissue oxygenation monitoring has allowed for the investigation of the relationships of physiologic correlates to BTpO 2 . Recent studies demonstrate a correlation between BTpO 2 values and fraction of inspired oxygen (FIO 2 ) as well as MAP (6) . Studies in patients suffering from severe brain injury have demonstrated a strong association between BTpO 2 and FIO 2 , and similarly, strong associations have also been made between BTpO 2 and MAP (7, 8) . However, controversy exists in regards to whether it provides clinically significant information (9, 10) .
Attempts have also been made to look at how BTpO 2 values are associated with outcome. Sustained BTpO 2 values below 5-15 mm Hg have been associated with poor outcome (8, 11) . Despite these efforts, the critical threshold identifying reversible cerebral hypoxia has not been definitively established. To consider the full potential of this relationship, better functional outcome measures may provide more insight.
Of the studies with adequate functional assessments after injury, the Glasgow Outcome Score and Extended Glasgow Outcome Score (GOSE) have been the most widely used (12, 13) . More finely grained scales such as the Disability Ratings Scale and Functional Status Examination (FSE) may provide added sensitivity (14 -16) . We anticipate that the FSE is best suited to measure subtle changes that are likely attributed to hypoxic secondary insults (17) .
Lastly, there has been a historical focus in the management of ICP and CPP to prevent cerebral ischemia, and thus tissue hypoxia. Recent studies have shown that cerebral ischemia may occur under normal ICP and MAP, as a result of impaired autoregulation, microvasculature abnormalities, and/or subtle edematous changes (9, 10, 18 -20) . Our hope is that BTpO 2 values may be a direct and accessible parameter to define the critical value(s) for initiating compensatory treatments for when brain tissue hypoxia occurs.
In this study, we sought to extend previous observations of the cerebral circulation by comparing hourly BTpO 2 records with ICP to evaluate the utility of BTpO 2 as a more informative measure than CPP. The second objective was to characterize hourly hypoxic periods (epochs) with respect to MAP, ICP, CPP, partial pressure of arterial carbon dioxide (PaCO 2 ), and hemoglobin (hemoglobin). In addition to these physiologic correlates of the acute care setting, we compared BTpO 2 with the functional outcome measures by the GOSE and the more detailed FSE administered 6 -9 months after injury. It is our long-term goal to address the clinical efficacy of monitoring brain tissue oxygenation in TBI patients.
METHODS
Patients. The data for this study were collected retrospectively from a subset of an ongoing prospective observational cohort study, assessing predictors of outcome in individuals with moderate to severe TBI. The study was approved by the Institutional Review Board of the University of Texas Southwestern Medical Center. Eligible patients were enrolled between July 2004 and December 2005. Participants were 14 yrs of age or older suffering from a brain injury consistent with a traumatic mechanism and the requirement for ICP and brain tissue oxygen monitoring. Exclusion criteria were preexisting conditions that may compromise cognitive functions (i.e., intracranial tumor, stroke, epilepsy, multiple sclerosis, arteriovenous malformation, human immunodeficiency virus encephalopathy, brain abscesses, Alzheimer's disease, Parkinson's disease, and meningitis), prisoners, and homeless patients. Informed consent was obtained from the patient's surrogates by a clinical research nurse not involved in the patient's care according to local IRB guidelines and national standards. Both the current investigation and the parent study were approved by the University of Texas Southwestern Medical Center, and all patients (or their legal surrogates) signed informed consent documents.
The tissue oxygen electrode (Licox, Integra Neurosciences) was placed 2-3 cm below the dura in uninvolved white matter of the frontal cortex separated by at least 1 cm from the ICP monitor (all received external ventricular drainage catheters; one subject also received a Camino intraparenchymal pressure monitor) introduced through the same cranial opening. Radiologic findings on computed tomography were recorded to confirm electrode placement.
Intensive care unit (ICU) nurses recorded hourly determinations of BTpO 2 , MAP, ICP, and FIO 2 in the medical record. Hemoglobin and PaCO 2 values were recorded when the arterial blood gas specimen was obtained. For purposes of analysis, these values were assumed to be constant between recorded chart values and were carried forward to accompany hourly BTpO 2 values. Age, sex, length of ICU stay, packed red blood cell transfusion, administration of barbiturates, and mortality were recorded. Glasgow Coma Score at entry to emergency room and Injury Severity Score were also collected. Functional outcome assessments were intended from 6 to 9 months after head injury. Two subjects were lost to follow-up after repeated attempts to contact them over several months.
Follow-up Measures. The GOSE and FSE were used in structured follow-up interviews to quantify outcome in person or over the phone according to the published questionnaires (14 -16, 21) . In situations when it was not possible for the survivor to complete the questionnaires, the primary caregiver was allowed to provide this information. The GOSE encompasses a wide range of patient outcomes through the implementation of an eight-point ordinal scale with higher scores associated with better outcomes. It had been introduced to address the insensitivity of the original Glasgow Outcome Score (21) . Categories are subdivided into upper and lower stratifications for the outcomes of "severely disabled" (3, 4), "moderately disabled" (5, 6) , and "good recovery" (7, 8) whereas death is scored as "1" and "persistent vegetative state" as "2" (21). Despite the widespread familiarity of this scale, the GOSE still suffers from low sensitivity (16) . We believe the FSE is better suited to detect subtle deficits likely to be associated with ischemic insults (14) .
The FSE assess functional differences between preinjury and postinjury status across the following ten domains: personal care, ambulation, major activity involving work/school, home management, leisure/recreation, travel, social integration, standard of living, financial independence, and executive functioning. For each domain, a four-point ordinal scale from "1" to "4" is given to determine the disability severity, where lower scores are associated with better outcome. A rating of "1" signifies no change from preinjury; "2" for difficulty in performing activity, but still total independence; and "3" for significant dependence on others some of the time to perform activities in that area; and "4" for complete dependence on others in that area. A total score of 41 designates death (14, 15 (11, 22) . Since we were more interested in assessing the effects of hypoxia on functional outcome, a higher threshold was used. Second, a survey of neurosurgeons participating in the National Institutes of Health TBI Clinical Trials Network revealed that 20 mm Hg is the commonly used threshold for instituting therapies (unpublished data). Third, the distribution of BTpO 2 in this study approximates a normal distribution, and 20 mm Hg is approximately 1 SD below the mean. For these reasons, the convention in our intensive care unit (ICU) was to use 20 mm Hg as the threshold for treatment.
Functional outcome relative to duration of hypoxia for each patient were analyzed using three approaches comparing proportions of hypoxia with disability ratings at follow-up. The first approach evaluated the appropriate cutoff for defining hypoxia in relation to functional outcome (as compared with the predefined criterion of BTpO 2 values Ͻ20 mm Hg). Fisher's exact test was use to calculate relative risks (RRs) of severe disability (GOSE 1-4) for patients with hypoxia for at least 20% of their entire monitoring record compared with those with hypoxic values Ͻ20% of the time. RRs for severe disability were calculated at different definitions of hypoxia at 5 mm Hg increments from 10 to 30 mm Hg (Graphpad Prism 4, San Diego, CA). The second comparison examined varying durations of hypoxia relative to the entire monitoring period (percent time hypoxia) using the predefined criteria of Ͻ20 mm Hg. Five percent increments of percent hours of hypoxia from 10% to 30% were studied (Graphpad Prism).
The final functional analysis relied on determining the disability for patients grouped according to the predefined hypoxia criteria (BTpO 2 Ͻ20 mm Hg) for at least 20% of their entire monitoring record. The Mann-Whitney nonparametric test was chosen to compare the respective noncontinuous scores obtained for the GOSE and then the FSE.
RESULTS
Population Characteristics. Twentyseven subjects (21 men, 6 women) yielded a total of 3041 hrs of data. The mean (SD) age was 25.8 yrs (10.1), median 22 ( Table 1) . The average (SD) length of stay in the ICU was 16.2 (6.0) days. Seventeen patients (63%) had computed tomography evidence of traumatic subarachnoid hemorrhage. All but two patients were intubated at entry to the emergency room. Two patients (15 and 19) who were not intubated initially subsequently deteriorated to a Glasgow Coma Score of 3 and required intubated. A total of 7% (220) of hourly epochs were excluded in the first comparison due to missing ICP or MAP values. In the second composite comparison, 2% (73) hourly epochs were excluded due to missing data analyzing the relationship between hypoxia and PaCO 2 or hemoglobin. In the third composite analysis, 2.3% (80) hourly epochs were excluded due to missing FIO 2 values. The mean (SD) ICP and BTpO 2 were 13.7 (6.6) cm H 2 O and 30.8 (13.6) mm Hg. Five patients expired. Table 1 shows that there were no significant differences in Glasgow Coma Score recorded at the time of Licox monitor placement, or in anatomical measures of injury severity (head Abbreviated Injury Score, Injury Severity Score) between those who had significant hypoxia (Ͼ20% hypoxia) and those with hypoxia Ͻ20% of the time. Table 2 presents the mean ICU Glasgow Coma scores with the hours of hypoxia and percent duration of hypoxia as well as the outcomes measures for all patients. Subjects 16 and 23 were designated lost to follow-up after multiple attempts to contact them over 2-3 months. Figure 1 shows the cumulative distribution of total hours of hypoxia and percent time of hypoxia (as compared with total hours patients were monitored).
Characterizing Brain Hypoxia. Twentytwo of 27 patients (81%) had at least one (Fig.  2A) . CPP below 60 mm Hg was associated with a significant risk of hypoxia (Table  3) . Similarly, MAP below 80 mm Hg and ICP above 20 cm H 2 O were independent risk factors for hypoxia. The distribution of BTpO 2 values to corresponding cerebral perfusion parameters graphically depicts the spread of those values for all hypoxic hourly records (Fig. 2) . No significant difference in hypoxia prevalence was found in regards to PaCO 2 from 25 to 40 mm Hg or hemoglobin from 7 to 12 g/dL.
Hypoxic BTpO 2 values and corresponding cerebral perfusion parameters were compared with those occurring during normoxic hourly records ( Table 4 ). The mean (SD) of CPP as well as MAP during hypoxia was significantly lower when independently compared with those occurring under normoxic values. Higher ICP was observed during hypoxia. Brain tissue hypoxia correlated significantly but weakly with MAP and CPP. Spearman's rho for BTpO 2 with MAP was 0.1958 (p Ͻ (Fig. 3) . During the initial 10 hrs recorded after device insertion, 11 of the 27 subjects (41%) had BTpO 2 values below 20 mm Hg. At 72 hrs postinsertion, 16 subjects still had monitors in place, and 5% between 20% of the hourly records taken from this smaller group were hypoxic.
Functional Outcome. To validate our selection of 20 mm Hg as our predefined threshold for hypoxia, we analyzed the functional outcome for 25 patients as a categorical variable (GOSE 1-4 was defined as poor outcome; GOSE 5-8 as good), and we determined the RR of poor outcome for subjects having at least 20% of hourly BTpO 2 values below 10, 15, 20, 25, and 30 mm Hg. Using a threshold of 25 or 30 mm Hg to define tissue hypoxia did not result in increased risk of poor outcome, whereas thresholds below 20 mm Hg resulted in a RR for poor outcome from 2.8 to 4.6 (Fig. 4A) . The RR at 10 and 15 mm Hg cutoff is lower (but not significantly so) from that at 20 mm Hg cutoff since several patients with hypoxic values between 15 and 20 mm Hg had unfavorable outcomes and thus are lumped with the anticipated favorable outcome group in the 10 and 15 mm Hg cutoff analyses. Lower thresholds to define hypoxia resulted in too few number of patients. Statistical significance was achieved only for the 20 mm Hg threshold. Conversely, hypoxia thresholds above 20 -25 mm Hg were associated with only a slight increase for good outcome. Also, use of Ͼ10% hypoxia time using these same thresholds did not change the conclusion of this analysis.
After confirming the appropriate cutoff for hypoxia, we analyzed functional outcomes relative to duration of hypoxia (percent time hypoxia) for each patient at intervals from 10% to 30% using our predefined definition of hypoxia as Ͻ20 mm Hg. Comparing the different intervals to GOSE values demonstrated that 20% hypoxia of recording time resulted in the optimal differentiation in outcome between hypoxic and normoxic groups (p ϭ 0.054) (Fig. 5) .
The mean (SD) GOSE for all 25 subjects was 4.1 Ϯ 2.1, and the mean (SD) FSE was 26.6 (10.7). The mean (SD) time to follow-up assessments was 7.5 months (1.7). Of the seven subjects experiencing hypoxia (below 20 mm Hg) for at least (Fig. 6 ). Only 1 (24) of the 18 subjects who had hypoxic values for Ͻ20% of their entire period of brain oxygen monitoring died. The cause of death in this individual was attributed to complications unrelated to the acute care of secondary insults associated with her TBI.
The mean time to outcomes assessment for this group with less hypoxia was 7.3 months. The difference in time to follow-up between the groups was not significant (p ϭ 0.35).
Of the five subjects who expired, the average brain tissue oxygen monitoring time was 71.2 Ϯ 50.2 hrs. Subjects 6 and 7 were hypoxic throughout their observation period (Table 2 ). Subjects 9 and 19 had a minimum of 26 hourly hypoxic values. The remaining subject (24) did not experience hypoxia during the period of monitoring and was transferred from the hospital to a nursing home facility in a stable condition. This patient expired from a complication of a percutaneous endoscopic gastrostomy procedure performed after she demonstrated a period of mental responsiveness. Nevertheless, she was assigned a GOSE score of 1 for the follow-up outcome.
Subjects 3, 11, and 19 received pentobarbital during their period of brain oxygen monitoring. Interestingly, two of these three patients (11 and 19) experienced lower mean BTpO 2 values during the duration of anesthetic-induced coma. However, with such a small sample size, no meaningful conclusions can be made from this finding.
DISCUSSION
The technology to measure brain tissue oxygen is accurate and readily available, but its clinical efficacy can only be adequately established by a well-designed randomized controlled trial. This retrospective analysis was undertaken to assist in hypothesis development, identifying critical hypoxia values, and to emphasize outcome measures that may be useful in such a study. We report on the distribution of BTpO 2 values that may be expected after severe TBI in the acute care setting and attempt to characterize the relationship of BTpO 2 to MAP, ICP, CPP, FIO 2 , PACO 2 , and hemoglobin.
In this study, brain tissue oxygen levels were measured using a commercially available monitoring system (Licox). This monitor has been available for Ͼ16 yrs, and it has been in clinical use in the United States since 2001. Its excellent reliability, sensitivity error Ͻ1%, low drift, and clinical utility have been well described (10, 23, 24) .
Although the respective distributions of elevated ICP and BTpO 2 values below our defined threshold were similar, only a small fraction of hypoxic (93 of 404 hrs; et al study, which had 101 subjects. Nevertheless, the relationship between BTpO 2 and CPP seems to account for both MAP and ICP influences with significantly more hypoxic values recorded at CPP below 70 mm Hg. One of the major goals of this study was to validate the commonly used 20 mm Hg threshold for brain tissue hypoxia by studying its association with CPP and functional outcome. We found that a hypoxia threshold of 25 and 30 mm Hg did not result in increased risk of poor outcome. The decision to use the hypoxia definition of 20 mm Hg was confirmed by the finding that values below 20 mm Hg were associated with severe disability.
Comparing hourly hypoxic with normoxic epochs, a statistically significant difference was detected in MAP and ICP. In addition to defining perfusion pressure associations with BTpO 2 values, we sought to characterize any existing relationship between PaCO 2 and hemoglobin. No clear associations were found across 395 hourly hypoxic episodes to PaCO 2 or hemoglobin. The lack of a relationship with the former is not surprising given the clinical practice of avoiding hypocapnia particularly in the first 24 hrs after injury. Over 90% of the data set consisted of PaCO 2 values greater than 30 mm Hg. The lack of association between BTpO 2 values to hemoglobin requires further study. BTpO 2 changes have been demonstrated relative to packed red blood cell transfusions, but the uncertain relationship between restrictive transfusion strategies and hypoxia after TBI remains unresolved (25, 26) . The anticipated inverse association of hemoglobin and hypoxic BTpO 2 values was not observed in our series. Although our study made the assumption that hemoglobin levels were constant between recorded chart values, we believe this is a generalizable approach to hemoglobin values in the actual neurocritical care setting. The findings support Smith et al who reported that subjects with hemoglobin values of 8.9 g/dL had concurrent BTpO 2 values of 29.1 mm Hg.
To assess the prevalence of tissue hypoxia as a function of time, all patients were evaluated in parallel for hypoxic hourly BTpO 2 records since monitor insertion. The results replicate previous studies that find a delay beyond the anticipated 2 hrs for the device to equilibrate brain tissue oxygenation (19, 23 Hours post-insertion % of patients with hourly hypoxia Figure 4 . A, Relative risk of severe disability (Extended Glasgow Outcome Score ͓GOSE͔ 1-4) for 25 subjects with Ͼ20% hypoxic values defined using five different thresholds (10, 15, 20, 25 , and 30 mm Hg) over entire observation period. In this type of analysis, we expect a peak in the relative risk (RR) curve at the optimal cutoff threshold. B, RR of moderate disability and/or good disability (GOSE 5-8) for 25 subjects with Ͼ20% hypoxia defined using five thresholds (10, 15, 20, 25 , and 30 mm Hg). insertion may be due to physiologic abnormalities in cerebral circulation or metabolism not attributable to barbiturates or device equilibration in situ. Although the benefit of interventions directed to reverse depressed BTpO 2 values is an area that requires additional prospective studies, the delay in equilibration from the Licox monitor may represent a means to identify subjects among the heterogeneous TBI population suffering from significant cerebral metabolic crisis (27) . Patients in our sample were predominantly young (median age 22 yrs). Older age has been associated with poorer outcomes after head injury (28) , and older subjects may be more susceptible to brain hypoxia. Thus, the relationships that we find among hypoxia thresholds, duration of hypoxia and functional outcomes may differ in older patients. In addition, the fraction of our patients with traumatic subarachnoid hemorrhage, 17 of 27, is higher than in other series. As traumatic subarachnoid hemorrhage may predispose to vasospasm, this may partly explain the high prevalence of hypoxic episodes in this cohort. Thus, our findings may not be completely generalizable to a wider population of TBI patients.
There is controversy regarding the optimal placement of the BTpO 2 probe. Some investigators favor placing the probe ipsilateral to side of maximal injury in some studies (22, 29 -33) , in the hope of monitoring the pericontusional penumbra, whereas others favor placing the probe in normal appearing tissue contralateral to visible contusions (9, 10, 20, 34 -42) in the hope of obtaining a measure that reflects global oxygenation status. Although there are positive and negative aspects to each, we favor placement of the probe in uninvolved cortex for the following reasons. First, it is the most feasible and reproducible, as BTpO 2 probe placement in the pericontusional area typically requires direct observation during craniotomy, or the use of stereotaxic guidance. Second, many patients with severe TBI at risk for tissue hypoxia do not have focal contusions. In our study only 10 of the patients (37%) had focal lesions, whereas 17 (63%) had only diffuse injuries. This is similar to results of other investigators (43) who reported that only 46% of patients had focal lesions that allowed placement of the BTpO 2 monitor in the pericontusional region. These investigators found significant differences in pBrO 2 depending on the site of insertion. Third, probes placed in the pericontusional region frequently fail to show reactivity to hyperoxia (44) or to augmentation of CPP (17) , indicating that they may be monitoring poorly perfused and irreversibly damaged tissue. Because of these reasons, the majority of the most recent and best available data favor probe placement in normal appearing cortex, contralateral to visible lesions (9, 10, 20, 34 -42) .
The use of functional outcome measures, such as the GOSE or the FSE, extends the findings of previous work that had focused primarily on mortality (17, 21, 33) . Subjects were stratified according to having greater than or less than 20% hypoxic episodes to delineate those we believed to have experienced significant periods of hypoxia from normal background variability, from device normalization, inaccurate readings at the end of life, and brain death. GOSE and FSE scores were poorer in subjects experiencing Ͼ20% of hourly hypoxia values during their entire record. We conclude that brain tissue hypoxia is a prognostic factor for poor functional outcome, as well as the growing evidence associating it with increased mortality.
CONCLUSION
Brain tissue oxygen monitoring provides an opportunity to measure tissue hypoxia in real time. Hypoxic episodes are common after severe TBI, and most are not associated with elevated ICP. Most patients with severe TBI had at least some hypoxic episodes. Tissue hypoxia was modestly associated with low CPP, but not with anemia or hypocapnia. Duration of hypoxia seems to be associated with differences in functional outcome. Use of 20 mm Hg as the lower limit of normal tissue oxygen pressure is justified by the association of hypoxic episodes defined by that threshold with poor functional outcome. We conclude that placement of brain tissue oxygen monitors in uninjured frontal cortex identifies many opportunities for therapeutic interventions that have the potential to improve outcome. Whether such treatments are effective will require randomized clinical trials. Our findings support the use of monitors placed in uninjured frontal cortex and the selection of 20 mm Hg as the value of tissue oxygenation below which therapies should be instituted. These results may be useful in the design of prospective treatment studies. 
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